Trial Outcomes & Findings for Bilateral Transversus Abdominis Plane Block With Exparel Verus Continuous Epidural Analgesia With Bupivacaine (NCT NCT02996227)

NCT ID: NCT02996227

Last Updated: 2024-01-31

Results Overview

Pain scores will be measured using a Verbal Response Scale (VRS). VRS is a scale from 0 to 10 where 0 signifies no pain and 10 signifies the worst pain ever experienced. The VRS will be recorded every 4 hours for 72 hours after discharge from the PACU. Summary statistics of pain scores are reported as means ± standard deviations of average pain during the first 72 postoperative hours

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

514 participants

Primary outcome timeframe

The Verbal Response Scale was recorded every 4 hours for 72 hours after discharge from the PACU.

Results posted on

2024-01-31

Participant Flow

Participant milestones

Participant milestones
Measure
TAP Block With Exparel
Bilateral Transversus Abdominis Plane (TAP) block procedure following injection of liposomal bupivacaine (Exparel) TAP block: Transversus Abdominis Plane (TAP) blocks will be performed preoperatively. An in-plane ultrasound will be used in TAP block procedure. EXPAREL: Once the target area is positioned, plain bupivacaine 0.25%, 20ml will be given to open the space and then single dose (10ml) of liposomal bupivacaine (Exparel) mixed with saline (10 ml) will be injected in each side. Total dose of Exparel will be 20 mL.
Epidural Analgesia With Bupivacaine
Epidural catheters with an infusion of Bupivacaine standard solution without additives Epidural analgesia: Epidural catheters will be inserted preoperatively. Bupivacaine: Once an epidural catheter is successfully positioned, an infusion will be initiated intraoperatively. Bupivacaine standard solution without additives will be prepared for each patient in epidural group.
Overall Study
STARTED
260
254
Overall Study
COMPLETED
255
243
Overall Study
NOT COMPLETED
5
11

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Bilateral Transversus Abdominis Plane Block With Exparel Verus Continuous Epidural Analgesia With Bupivacaine

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
TAP Block With Exparel
n=255 Participants
Bilateral Transversus Abdominis Plane (TAP) block procedure following injection of liposomal bupivacaine (Exparel) TAP block: Transversus Abdominis Plane (TAP) blocks will be performed preoperatively. An in-plane ultrasound will be used in TAP block procedure. EXPAREL: Once the target area is positioned, plain bupivacaine 0.25%, 20ml will be given to open the space and then single dose (10ml) of liposomal bupivacaine (Exparel) mixed with saline (10 ml) will be injected in each side. Total dose of Exparel will be 20 mL.
Epidural Analgesia With Bupivacaine
n=243 Participants
Epidural catheters with an infusion of Bupivacaine standard solution without additives Epidural analgesia: Epidural catheters will be inserted preoperatively. Bupivacaine: Once an epidural catheter is successfully positioned, an infusion will be initiated intraoperatively. Bupivacaine standard solution without additives will be prepared for each patient in epidural group.
Total
n=498 Participants
Total of all reporting groups
Age, Continuous
55 years
STANDARD_DEVIATION 14 • n=99 Participants
56 years
STANDARD_DEVIATION 14 • n=107 Participants
55 years
STANDARD_DEVIATION 14 • n=206 Participants
Sex: Female, Male
Female
160 Participants
n=99 Participants
161 Participants
n=107 Participants
321 Participants
n=206 Participants
Sex: Female, Male
Male
95 Participants
n=99 Participants
82 Participants
n=107 Participants
177 Participants
n=206 Participants
Race/Ethnicity, Customized
White
221 Participants
n=99 Participants
213 Participants
n=107 Participants
434 Participants
n=206 Participants
Race/Ethnicity, Customized
Other
34 Participants
n=99 Participants
30 Participants
n=107 Participants
64 Participants
n=206 Participants
ASA Status
I
2 Participants
n=99 Participants
2 Participants
n=107 Participants
4 Participants
n=206 Participants
ASA Status
II
70 Participants
n=99 Participants
67 Participants
n=107 Participants
137 Participants
n=206 Participants
ASA Status
III
171 Participants
n=99 Participants
167 Participants
n=107 Participants
338 Participants
n=206 Participants
ASA Status
IV
12 Participants
n=99 Participants
6 Participants
n=107 Participants
18 Participants
n=206 Participants
ASA Status
Unknown
0 Participants
n=99 Participants
1 Participants
n=107 Participants
1 Participants
n=206 Participants
Procedure type
Open
188 Participants
n=99 Participants
181 Participants
n=107 Participants
369 Participants
n=206 Participants
Procedure type
Laparoscopic
67 Participants
n=99 Participants
62 Participants
n=107 Participants
129 Participants
n=206 Participants
Surgery Duration
5.7 hours
STANDARD_DEVIATION 2.5 • n=99 Participants
5.6 hours
STANDARD_DEVIATION 2.5 • n=107 Participants
5.7 hours
STANDARD_DEVIATION 2.5 • n=206 Participants
Type of Surgery
Bariatric
0 Participants
n=99 Participants
1 Participants
n=107 Participants
1 Participants
n=206 Participants
Type of Surgery
Colorectal
171 Participants
n=99 Participants
167 Participants
n=107 Participants
338 Participants
n=206 Participants
Type of Surgery
Gynecologica
55 Participants
n=99 Participants
42 Participants
n=107 Participants
97 Participants
n=206 Participants
Type of Surgery
Urological
2 Participants
n=99 Participants
5 Participants
n=107 Participants
7 Participants
n=206 Participants
Type of Surgery
Other
27 Participants
n=99 Participants
28 Participants
n=107 Participants
55 Participants
n=206 Participants

PRIMARY outcome

Timeframe: The Verbal Response Scale was recorded every 4 hours for 72 hours after discharge from the PACU.

Population: Two patients had missing outcomes due to the cancellation of surgery in Epidural analgesia with Bupivacaine group.

Pain scores will be measured using a Verbal Response Scale (VRS). VRS is a scale from 0 to 10 where 0 signifies no pain and 10 signifies the worst pain ever experienced. The VRS will be recorded every 4 hours for 72 hours after discharge from the PACU. Summary statistics of pain scores are reported as means ± standard deviations of average pain during the first 72 postoperative hours

Outcome measures

Outcome measures
Measure
TAP Block With Exparel
n=255 Participants
Bilateral Transversus Abdominis Plane (TAP) block procedure following injection of liposomal bupivacaine (Exparel) TAP block: Transversus Abdominis Plane (TAP) blocks will be performed preoperatively. An in-plane ultrasound will be used in TAP block procedure. EXPAREL: Once the target area is positioned, plain bupivacaine 0.25%, 20ml will be given to open the space and then single dose (10ml) of liposomal bupivacaine (Exparel) mixed with saline (10 ml) will be injected in each side. Total dose of Exparel will be 20 mL.
Epidural Analgesia With Bupivacaine
n=241 Participants
Epidural catheters with an infusion of Bupivacaine standard solution without additives Epidural analgesia: Epidural catheters will be inserted preoperatively. Bupivacaine: Once an epidural catheter is successfully positioned, an infusion will be initiated intraoperatively. Bupivacaine standard solution without additives will be prepared for each patient in epidural group.
VRS Pain Score
4.3 score on a scale
Standard Deviation 1.8
4.2 score on a scale
Standard Deviation 1.8

PRIMARY outcome

Timeframe: During the 72 hours after discharge from the PACU.

Population: Two patients had missing outcomes due to the cancellation of surgery in Epidural analgesia with Bupivacaine group.

Opioid consumption will be measured as the total amount of opioids (converted to morphine sulfate equivalents) used during the 72 hours after the end of surgery.

Outcome measures

Outcome measures
Measure
TAP Block With Exparel
n=255 Participants
Bilateral Transversus Abdominis Plane (TAP) block procedure following injection of liposomal bupivacaine (Exparel) TAP block: Transversus Abdominis Plane (TAP) blocks will be performed preoperatively. An in-plane ultrasound will be used in TAP block procedure. EXPAREL: Once the target area is positioned, plain bupivacaine 0.25%, 20ml will be given to open the space and then single dose (10ml) of liposomal bupivacaine (Exparel) mixed with saline (10 ml) will be injected in each side. Total dose of Exparel will be 20 mL.
Epidural Analgesia With Bupivacaine
n=241 Participants
Epidural catheters with an infusion of Bupivacaine standard solution without additives Epidural analgesia: Epidural catheters will be inserted preoperatively. Bupivacaine: Once an epidural catheter is successfully positioned, an infusion will be initiated intraoperatively. Bupivacaine standard solution without additives will be prepared for each patient in epidural group.
Total Opioid Consumption
56 mg
Interval 20.0 to 122.0
35 mg
Interval 13.0 to 94.0

SECONDARY outcome

Timeframe: During the initial 72 postoperative hours.

defined as the total duration of time patients spent sitting or standing, as determined by the mobile monitoring system during the initial 72 postoperative hours.

Outcome measures

Outcome measures
Measure
TAP Block With Exparel
n=123 Participants
Bilateral Transversus Abdominis Plane (TAP) block procedure following injection of liposomal bupivacaine (Exparel) TAP block: Transversus Abdominis Plane (TAP) blocks will be performed preoperatively. An in-plane ultrasound will be used in TAP block procedure. EXPAREL: Once the target area is positioned, plain bupivacaine 0.25%, 20ml will be given to open the space and then single dose (10ml) of liposomal bupivacaine (Exparel) mixed with saline (10 ml) will be injected in each side. Total dose of Exparel will be 20 mL.
Epidural Analgesia With Bupivacaine
n=118 Participants
Epidural catheters with an infusion of Bupivacaine standard solution without additives Epidural analgesia: Epidural catheters will be inserted preoperatively. Bupivacaine: Once an epidural catheter is successfully positioned, an infusion will be initiated intraoperatively. Bupivacaine standard solution without additives will be prepared for each patient in epidural group.
Cumulative Duration of Activity
1.1 hours
Interval 0.2 to 3.4
1.0 hours
Interval 0.1 to 3.8

SECONDARY outcome

Timeframe: The first, second and third postoperative mornings

We will use 4-point Opioid-Related Symptom Distress Scale (ORSDS) to evaluate the frequency, severity, and bothersomeness of: nausea, vomiting, constipation, difficulty passing urine, difficulty concentrating,drowsiness or difficulty staying awake, feeling lightheaded or dizzy,feeling confused, feelings of general fatigue or weakness, itchiness, dry mouth, and headache. Severity: 1=Slightly severe 2=Moderately severe 3=Severe 4=Very severe; Frequency: 1=Rarely 2=Occasionally 3=Frequently 4=Almost constantly; Bothersomeness (rescaled to a 4-point scale): 0.8=not at all 1.6=a little bit 2.4= somewhat 3.2=quite a bit 4.0=very much. If a patient did not experience the symptom in the past 24 hours, a score of 0 was assigned to each domain. Opioid-related side effect is the sum of the patient's frequency, severity, and bothersomeness, scored from 0 to 12. Higher scores indicate greater severity.

Outcome measures

Outcome measures
Measure
TAP Block With Exparel
n=203 Participants
Bilateral Transversus Abdominis Plane (TAP) block procedure following injection of liposomal bupivacaine (Exparel) TAP block: Transversus Abdominis Plane (TAP) blocks will be performed preoperatively. An in-plane ultrasound will be used in TAP block procedure. EXPAREL: Once the target area is positioned, plain bupivacaine 0.25%, 20ml will be given to open the space and then single dose (10ml) of liposomal bupivacaine (Exparel) mixed with saline (10 ml) will be injected in each side. Total dose of Exparel will be 20 mL.
Epidural Analgesia With Bupivacaine
n=199 Participants
Epidural catheters with an infusion of Bupivacaine standard solution without additives Epidural analgesia: Epidural catheters will be inserted preoperatively. Bupivacaine: Once an epidural catheter is successfully positioned, an infusion will be initiated intraoperatively. Bupivacaine standard solution without additives will be prepared for each patient in epidural group.
Opioid-related Side Effect
POD 2
4.9 score on a scale
Interval 1.9 to 9.1
4.5 score on a scale
Interval 1.3 to 8.4
Opioid-related Side Effect
POD 1
5.8 score on a scale
Interval 2.3 to 9.7
5.5 score on a scale
Interval 2.8 to 9.6
Opioid-related Side Effect
POD 3
3.8 score on a scale
Interval 1.5 to 8.3
3.7 score on a scale
Interval 0.9 to 8.7

SECONDARY outcome

Timeframe: Data was recorded at 15-s intervals during the initial 72 postoperative hours.

Visi mobile patient monitoring system will be used to obtain the blood pressure of the patient for 72 hours. Data was recorded at 15-s intervals and downloaded daily to a laptop. We re-defined postoperative hypotension as any MAP \<65 mmHg, because few patients experienced such profound hypotension as originally planned and because papers published since the trial were designed to identify 65 mmHg as the harm threshold for both myocardial and renal injury. Summary statistics of hemodynamic instability are reported as means ± standard deviations of average MAP during the first 72 postoperative hours.

Outcome measures

Outcome measures
Measure
TAP Block With Exparel
n=123 Participants
Bilateral Transversus Abdominis Plane (TAP) block procedure following injection of liposomal bupivacaine (Exparel) TAP block: Transversus Abdominis Plane (TAP) blocks will be performed preoperatively. An in-plane ultrasound will be used in TAP block procedure. EXPAREL: Once the target area is positioned, plain bupivacaine 0.25%, 20ml will be given to open the space and then single dose (10ml) of liposomal bupivacaine (Exparel) mixed with saline (10 ml) will be injected in each side. Total dose of Exparel will be 20 mL.
Epidural Analgesia With Bupivacaine
n=119 Participants
Epidural catheters with an infusion of Bupivacaine standard solution without additives Epidural analgesia: Epidural catheters will be inserted preoperatively. Bupivacaine: Once an epidural catheter is successfully positioned, an infusion will be initiated intraoperatively. Bupivacaine standard solution without additives will be prepared for each patient in epidural group.
Hemodynamic Instability, Defined as Mean Arterial Pressure (MAP) <55 mmHg or Systolic Blood Pressure <80 mmHg.
41 mmHg
Standard Deviation 31
57 mmHg
Standard Deviation 48

SECONDARY outcome

Timeframe: The first and third postoperative mornings

Quality of recovery (QoR) will be measured using QoR-15 questionnaire which includes 15 11-point numerical rating scale. For positive items, 0 = "none of the time \[poor\]" to 10 = "all of the time \[excellent\]"; Conversely, for negative items, 10 = "none of the time \[excellent\]" to 0 = "all of the time \[poor\]". Quality of recovery is the sum of all the 15 questions, with a score ranging from 0 (extremely poor QoR) to 150 (excellent QoR).

Outcome measures

Outcome measures
Measure
TAP Block With Exparel
n=203 Participants
Bilateral Transversus Abdominis Plane (TAP) block procedure following injection of liposomal bupivacaine (Exparel) TAP block: Transversus Abdominis Plane (TAP) blocks will be performed preoperatively. An in-plane ultrasound will be used in TAP block procedure. EXPAREL: Once the target area is positioned, plain bupivacaine 0.25%, 20ml will be given to open the space and then single dose (10ml) of liposomal bupivacaine (Exparel) mixed with saline (10 ml) will be injected in each side. Total dose of Exparel will be 20 mL.
Epidural Analgesia With Bupivacaine
n=198 Participants
Epidural catheters with an infusion of Bupivacaine standard solution without additives Epidural analgesia: Epidural catheters will be inserted preoperatively. Bupivacaine: Once an epidural catheter is successfully positioned, an infusion will be initiated intraoperatively. Bupivacaine standard solution without additives will be prepared for each patient in epidural group.
Quality of Recovery After Anesthesia
POD 1
102 score on a scale
Standard Deviation 26
100 score on a scale
Standard Deviation 24
Quality of Recovery After Anesthesia
POD 3
111 score on a scale
Standard Deviation 23
111 score on a scale
Standard Deviation 22

SECONDARY outcome

Timeframe: From date of hospital admission until the date of hospital discharge or date of death from any cause, whichever came first, assessed up to 100 weeks

The length of hospital stay will be measured as days.

Outcome measures

Outcome measures
Measure
TAP Block With Exparel
n=255 Participants
Bilateral Transversus Abdominis Plane (TAP) block procedure following injection of liposomal bupivacaine (Exparel) TAP block: Transversus Abdominis Plane (TAP) blocks will be performed preoperatively. An in-plane ultrasound will be used in TAP block procedure. EXPAREL: Once the target area is positioned, plain bupivacaine 0.25%, 20ml will be given to open the space and then single dose (10ml) of liposomal bupivacaine (Exparel) mixed with saline (10 ml) will be injected in each side. Total dose of Exparel will be 20 mL.
Epidural Analgesia With Bupivacaine
n=241 Participants
Epidural catheters with an infusion of Bupivacaine standard solution without additives Epidural analgesia: Epidural catheters will be inserted preoperatively. Bupivacaine: Once an epidural catheter is successfully positioned, an infusion will be initiated intraoperatively. Bupivacaine standard solution without additives will be prepared for each patient in epidural group.
Length of Hospital Stay
4.0 days
Interval 3.0 to 7.0
4.0 days
Interval 3.0 to 7.0

OTHER_PRE_SPECIFIED outcome

Timeframe: Data was recorded at 15-s intervals during the initial 72 postoperative hours.

ViSi mobile (Sotera Wireless) patient monitoring system will be used to obtain vital signs including SpO2 of the patient for 72 hours. Data was recorded at 15-s intervals and downloaded daily to a laptop. The outcome is area-under-the-curve for saturation over time with the threshold set at 90%.

Outcome measures

Outcome measures
Measure
TAP Block With Exparel
n=123 Participants
Bilateral Transversus Abdominis Plane (TAP) block procedure following injection of liposomal bupivacaine (Exparel) TAP block: Transversus Abdominis Plane (TAP) blocks will be performed preoperatively. An in-plane ultrasound will be used in TAP block procedure. EXPAREL: Once the target area is positioned, plain bupivacaine 0.25%, 20ml will be given to open the space and then single dose (10ml) of liposomal bupivacaine (Exparel) mixed with saline (10 ml) will be injected in each side. Total dose of Exparel will be 20 mL.
Epidural Analgesia With Bupivacaine
n=118 Participants
Epidural catheters with an infusion of Bupivacaine standard solution without additives Epidural analgesia: Epidural catheters will be inserted preoperatively. Bupivacaine: Once an epidural catheter is successfully positioned, an infusion will be initiated intraoperatively. Bupivacaine standard solution without additives will be prepared for each patient in epidural group.
Duration of Hypoxemia
1.4 min/h
Interval 0.2 to 7.7
2.8 min/h
Interval 0.3 to 8.4

OTHER_PRE_SPECIFIED outcome

Timeframe: At the 90-day follow up

Defined by the presence of pain at three months and its characteristics as determined by Modified Brief Pain Inventory (MBPI) questionnaires. The modified BPI contains 4 intensity items and 5 interference items with 0-to-10 numerical rating scales. For intensity items: 0 = "no pain" and 10 = "pain as bad as you can imagine."; and for interference items, 0 = "does not interfere" and 10 = "interferes completely." The pain intensity is the sum of the patient's worst, average, least, and current pain intensity, with a score ranging from 0 (no pain) to 40 (pain as bad as you can imagine); and pain Interference is the sum of walking ability, mood, sleep, relations with others, and ability to concentrate, with a score ranging from 0 (does not interfere) to 50 (interferes completely).

Outcome measures

Outcome measures
Measure
TAP Block With Exparel
n=59 Participants
Bilateral Transversus Abdominis Plane (TAP) block procedure following injection of liposomal bupivacaine (Exparel) TAP block: Transversus Abdominis Plane (TAP) blocks will be performed preoperatively. An in-plane ultrasound will be used in TAP block procedure. EXPAREL: Once the target area is positioned, plain bupivacaine 0.25%, 20ml will be given to open the space and then single dose (10ml) of liposomal bupivacaine (Exparel) mixed with saline (10 ml) will be injected in each side. Total dose of Exparel will be 20 mL.
Epidural Analgesia With Bupivacaine
n=54 Participants
Epidural catheters with an infusion of Bupivacaine standard solution without additives Epidural analgesia: Epidural catheters will be inserted preoperatively. Bupivacaine: Once an epidural catheter is successfully positioned, an infusion will be initiated intraoperatively. Bupivacaine standard solution without additives will be prepared for each patient in epidural group.
Persistent Postoperative Incisional Pain- MBPI Pain Intensity
8 score on a scale
Interval 5.0 to 17.0
12 score on a scale
Interval 5.0 to 21.0

OTHER_PRE_SPECIFIED outcome

Timeframe: At the 90-day follow up

Defined by the presence of pain at three months and its characteristics as determined by Modified Brief Pain Inventory (MBPI) questionnaires. The modified BPI contains 4 intensity items and 5 interference items with 0-to-10 numerical rating scales. For intensity items: 0 = "no pain" and 10 = "pain as bad as you can imagine."; and for interference items, 0 = "does not interfere" and 10 = "interferes completely." The pain intensity is the sum of the patient's worst, average, least, and current pain intensity, with a score ranging from 0 (no pain) to 40 (pain as bad as you can imagine); and pain Interference is the sum of walking ability, mood, sleep, relations with others, and ability to concentrate, with a score ranging from 0 (does not interfere) to 50 (interferes completely).

Outcome measures

Outcome measures
Measure
TAP Block With Exparel
n=59 Participants
Bilateral Transversus Abdominis Plane (TAP) block procedure following injection of liposomal bupivacaine (Exparel) TAP block: Transversus Abdominis Plane (TAP) blocks will be performed preoperatively. An in-plane ultrasound will be used in TAP block procedure. EXPAREL: Once the target area is positioned, plain bupivacaine 0.25%, 20ml will be given to open the space and then single dose (10ml) of liposomal bupivacaine (Exparel) mixed with saline (10 ml) will be injected in each side. Total dose of Exparel will be 20 mL.
Epidural Analgesia With Bupivacaine
n=54 Participants
Epidural catheters with an infusion of Bupivacaine standard solution without additives Epidural analgesia: Epidural catheters will be inserted preoperatively. Bupivacaine: Once an epidural catheter is successfully positioned, an infusion will be initiated intraoperatively. Bupivacaine standard solution without additives will be prepared for each patient in epidural group.
Persistent Postoperative Incisional Pain- MBPI Pain Interference
14 score on a scale
Interval 3.0 to 34.0
17 score on a scale
Interval 0.0 to 38.0

Adverse Events

TAP Block With Exparel

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Epidural Analgesia With Bupivacaine

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Fabio Rodriguez

Cleveland Clinic

Phone: 215 444-9950

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place